Prothrombotic recombinant activated factor VII in intracerebral haemorrhage: FAST but not focused?

The Lancet Neurology

Volumn 7, Issue 8, 2008, Pages 670-672

  Bogousslavsky, Julien ^a   Piechowski Jozwiak, Bartlomiej ^b  

^a Genolier Swiss Medical Network SA   (Switzerland)

^b LUX MED Medical Clinic   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG SAFETY; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

CEREBRAL HEMORRHAGE; CLINICAL TRIALS, PHASE III AS TOPIC; COAGULANTS; FACTOR VIII; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS;

EID: 47049090943     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(08)70147-9     Document Type: Letter

References (5)

1. Institute of Neurological Disorders and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
2. Mayer S., Brun N., Begtrup K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 (2005) 777-785
3. Mayer S., Brun N., Begrtup K., et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358 (2008) 2127-2137
4. Bamford J., Dennis M., Sandercock P., Burn J., and Warlaw C. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry 53 (1990) 824-829
5. Suri M., Suarez J., Rodrigue T., et al. Effect of treatment of elevated blood pressure on neurological deterioration in patients with acute intracerebral hemorrhage. Neurocrit Care (2008) 10.1007/s12028-008-9106-7 published online May 28.